ChemMedChem

简称 CHEMMEDCHEM ·GERMANY ·出版周期 Monthly ·年均收录 264 篇

3.4

最新影响因子

4.20%

自引率

约75%

投稿难度

平均1.0个月

审稿周期

期刊简介

ChemMedChem是一本专注于药物化学和药物发现领域的国际学术期刊，其ISSN号为1860-7179。该杂志由Wiley-VCH出版社出版，出版地为德国，出版周期为半月刊。ChemMedChem目前被SCI收录，2022年的影响因子为3.4，属于中科院分区中的化学大类3区。该杂志为非开放获取（非OA）期刊。ChemMedChem的发文特点集中在药物化学、药物设计、药物发现及相关跨学科研究，涵盖小分子药物、生物活性化合物、靶点识别与验证等领域。杂志注重发表高质量的研究论文、通讯和综述，强调创新性与实用性。从质量与风险来看，ChemMedChem作为老牌期刊，学术声誉较好，但影响因子相对中等，投稿时需注意研究内容的创新性和与期刊主题的契合度。总体而言，该杂志适合药物化学领域的研究者投稿，尤其适合关注分子设计与药物发现的研究成果。

影响因子趋势

近期发表

10.1002/cmdc.v21.18 2026-09-14

Potent Caspase‐1 Antagonists From Dihydropyridine Derivatives: In Vitro Fluorescence Assays and Cell Imaging 2026-09-21

Synthesis, Biological Evaluation, and Molecular Modeling of Novel Pyrimidine Scaffolds as Prospective Anticancer and Antimicrobial Agents 2026-09-18

Peptide‐Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives 2026-09-17

Corrigendum to “Rational Design of Ruthenium Complexes Containing 2,6‐Bis(benzimidazolyl)pyridine Derivatives With Radiosensitization Activity by Enhancing p53 Activation” 2026-09-16

New 1,3‐Oxazole and 1,2,4‐Oxadiazole Derivatives as Novel Agents Against Human Rhinovirus and Cytomegalovirus 2026-09-16

Linker Optimization of cMYC RIBOTAC for Efficient cMYC Modulation 2026-09-16

10.1002/cmdc.v21.17 2026-08-28

Tearing Down Scientific Boundaries: Frontiers in Medicinal Chemistry 2026 2026-09-14

Schiff Base Derivatives of Benzothiazole and Benzamide as Promising Antimicrobial Agents: Integrated In Silico and In Vitro Evaluation 2026-09-14